Chris Van Tuyl

Chris Van Tuyl joined Dermavant in 2018 from Sacks Tierney, where he was a partner in the firm’s corporate practice group. He previously served as Corporate Secretary, Chief Compliance Officer, and Associate General Counsel at Rayonier where he oversaw key aspects of the company’s multi-billion-dollar spinoff of its chemicals business in 2014, and as Associate General Counsel at Medicis Pharmaceuticals through the company’s $2.6 billion acquisition in 2012. Prior to joining Medicis, Mr. Van Tuyl was a corporate attorney at Squire Sanders & Dempsey and Clifford Chance. He received his B.S. in Finance summa cum laude from Arizona State University and his J.D. from Duke University School of Law.